Friday, March 30, 2007

Globorix: GSK - good pharma or bad pharma?

GSKEurope's largest drugs company, GSK, is starting the registration process for a vaccine from which it never expects to make money. So GSK is the good guy, saving the planet, right? Or is it after entry to new markets in which it has not been able to make much headway previously? Is Globorix a loss leader? How would I feel if I was a GSK shareholder (I'm not) - it's not a charity - what about my investment/pension fund?

GSK: Good pharma or bad pharma? Discuss.

Download MP3  

1 comment:

  1. GSK not making money?

    I'd like to write more on this subject but my concentration has just been broken by the pig that just flew past my window.